177 related articles for article (PubMed ID: 36398204)
1. Novel prognostic signature based on HRAS, MAPK3 and TFRC identified to be associated with ferroptosis and the immune microenvironment in hepatocellular carcinoma.
Sun H; Qian X; Yang W; Zhou W; Zhou C; Liu S; Shi H; Tian W
Am J Transl Res; 2022; 14(10):6924-6940. PubMed ID: 36398204
[TBL] [Abstract][Full Text] [Related]
2. Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma.
Wen K; Yan Y; Shi J; Hu L; Wang W; Liao H; Li H; Zhu Y; Mao K; Xiao Z
Front Mol Biosci; 2021; 8():809672. PubMed ID: 34977159
[No Abstract] [Full Text] [Related]
3. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis.
Wang W; Pan F; Lin X; Yuan J; Tao C; Wang R
Front Genet; 2022; 13():907331. PubMed ID: 35938001
[No Abstract] [Full Text] [Related]
4. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
5. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
6. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
Xu L; Zheng Q; Liu W
BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
[TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma.
Zheng C; Peng Y; Wang H; Wang Y; Liu L; Zhao Q
Pharmgenomics Pers Med; 2023; 16():39-58. PubMed ID: 36726530
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Prognosis and Immunotherapy in Hepatocellular Carcinoma.
Zhang B; Zhao J; Liu B; Shang Y; Chen F; Zhang S; He J; Fan Y; Tan K
Front Mol Biosci; 2022; 9():940575. PubMed ID: 35847985
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma.
Wang L; Ge X; Zhang Z; Ye Y; Zhou Z; Li M; Yan H; Wu L; Bai Q; Li J; Zhu J; Wang Y
Front Genet; 2021; 12():682082. PubMed ID: 34745200
[No Abstract] [Full Text] [Related]
10. Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma.
Xie H; Shi M; Liu Y; Cheng C; Song L; Ding Z; Jin H; Cui X; Wang Y; Yao D; Wang P; Yao M; Zhang H
Front Immunol; 2022; 13():914977. PubMed ID: 36032107
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of four ferroptosis-related gene signatures and their correlations with immune implication in hepatocellular carcinoma.
Zhang Y; Ren H; Zhang C; Li H; Guo Q; Xu H; Cui L
Front Immunol; 2022; 13():1028054. PubMed ID: 36304446
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma.
Chen ZA; Tian H; Yao DM; Zhang Y; Feng ZJ; Yang CJ
Front Oncol; 2021; 11():738477. PubMed ID: 34568075
[TBL] [Abstract][Full Text] [Related]
13. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
[TBL] [Abstract][Full Text] [Related]
14. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.
Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G
Front Immunol; 2022; 13():929089. PubMed ID: 35874689
[TBL] [Abstract][Full Text] [Related]
15. A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma.
Liang JY; Wang DS; Lin HC; Chen XX; Yang H; Zheng Y; Li YH
Int J Biol Sci; 2020; 16(13):2430-2441. PubMed ID: 32760210
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a combined hypoxia and ferroptosis prognostic signature for breast cancer.
Zhong J; Shen X; Zhou J; Yu H; Wang B; Sun J; Wang J; Liu F
Front Oncol; 2023; 13():1077342. PubMed ID: 36998462
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma.
Wang Q; Wang B; Ma X; Zhuang H; Xie Z; Tang C; Tan W; Yang L; Shang C; Chen Y
J Hepatocell Carcinoma; 2023; 10():1-16. PubMed ID: 36647389
[TBL] [Abstract][Full Text] [Related]
18. A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma.
Wang X; Meng Y; Liu C; Yang H; Zhou S
J Oncol; 2022; 2022():9103259. PubMed ID: 36131791
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer.
Sun J; Yue W; You J; Wei X; Huang Y; Ling Z; Hou J
Front Oncol; 2021; 11():730716. PubMed ID: 34557413
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma.
Shi J; Wu P; Sheng L; Sun W; Zhang H
Cancer Cell Int; 2021 Dec; 21(1):669. PubMed ID: 34906147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
